| FDA approves contraceptive for acne control
The U.S. Food and Drug Administration has approved a new use of Bayer Schering Pharma AG's drug YAZ to allow it to be used to treat moderate acne in women who also want to use an oral contraceptive for birth control, the company said Monday. With the approval, YAZ becomes the first oral contraceptive approved by the FDA for three distinct uses, Bayer said in a statement. In addition to being approved for birth control use and now for acne control, it is also approved to treat the emotional and physical symptoms of premenstrual dysphoric disorder. "YAZ is the fastest growing oral contraceptive brand in the U.S.," said Phil Smits, head of Bayer Schering Pharma's women's healthcare unit. "We are convinced that through its unique features, YAZ will further strengthen our worldwide leading market position in the field of female contraception." .
Triax Pharmaceuticals Presents an Evening With General Colin L ...
WASHINGTON, Feb. 2 /PRNewswire-USNewswire/ -- Triax Pharmaceuticals, LLC, hosts an exquisite evening for over 350 people at the Grand Ballroom of the Willard Inter-Continental Hotel. Held in conjunction with the American Academy of Dermatology Annual Meeting (AAD), the evening will be attended by top dermatologists. The key speaker and guest of honor is General Colin L. Powell, USA (Ret.), the 65th Secretary of State. Triax is a leader in the anti-acne market, with their two unique prescription and cosmetic combination packages, Tretin-X(R) (tretinoin) and Minocin(R) (minocycline HCl) Pellet-filled Capsules P.A.C., which combine a prescription medication with comprehensive skin care, helping the nearly 20 million Americans who suffer with acne. Together with Triax, this prestigious group will join collectively from across the country to listen to General Colin Powell, named by US News & World Report as one of America's Best Leaders.
|
